Stryker Warren Jr., CEO and president of Urologix, will step down from his current position at the end of November. Warren had rejoined the company in June of 2008 after coming out of retirement. According to information released by the company, Warren will remain at Urologix on salary until March 29th of next year.
Once the transition to a new CEO is completed, Warren will switch from a salaried position at Urologix to the role of an outside consultant. According to a regulatory filing, Warren will earn $1000 per eight-hour period as an exterior consultant. He will also receive prorated compensation for partial work days.
A press release by Urologix provided a glowing review of this executive. In the press release, the company stated, “During his four-year tenure as CEO, [Warren] revitalized the company's relationships with the urologic community, organized the original patient education initiatives which have become the principal driver of the company's growth strategy, built a strong leadership team to include the recruitment of Mr. Fluet and steered the company through a difficult decline in the in-office BPH therapy market.”
During the transition period at Urologix, CFO Greg Fluet will serve as the CEO for the company. Fluet first joined the company one month after Warren took over in 2008.